Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$753M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$717M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$653M |
| 5 |
Microsoft
MSFT
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$427M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$380M |
| 3 |
STJ
St Jude Medical
STJ
|
+$235M |
| 4 |
JPMorgan Chase
JPM
|
+$211M |
| 5 |
LLTC
Linear Technology Corp
LLTC
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.74% |
| 2 | Healthcare | 5.25% |
| 3 | Financials | 4.26% |
| 4 | Communication Services | 3.9% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
CALL
Century Aluminum
CENX
$4.55B
| $617K | ﹤0.01% |
48,600
+34,100
| +235% | +$453K |
|
|
LFC
3152
CALL
DELISTED
China Life Insurance Company Ltd.
LFC
| $616K | ﹤0.01% |
40,200
+37,000
| +1,156% | +$548K |
|
3153
iShares Currency Hedged MSCI Japan ETF
HEWJ
$736M
| $615K | ﹤0.01% |
21,933
| – | – |
|
3154
iShares MSCI Switzerland ETF
EWL
$2.21B
| $614K | ﹤0.01% |
19,212
-10,412
| -35% | -$323K |
|
3155
Ryanair
RYAAY
$31.4B
| $614K | ﹤0.01% |
18,500
+11,500
| +164% | +$381K |
|
|
BID
3156
PUT
DELISTED
Sotheby's
BID
| $614K | ﹤0.01% |
13,500
+600
| +5% | +$25.7K |
|
3157
CALL
CBRE Group
CBRE
$42.7B
| $612K | ﹤0.01% |
17,600
-1,700
| -9% | -$56.9K |
|
|
KS
3158
DELISTED
KapStone Paper and Pack Corp.
KS
| $612K | ﹤0.01% |
26,471
+13,676
| +107% | +$316K |
|
3159
PUT
BGC Group
BGC
$4.97B
| $611K | ﹤0.01% |
83,659
+62,355
| +293% | +$448K |
|
3160
Quad
QUAD
$515M
| $611K | ﹤0.01% |
24,254
+12,893
| +113% | +$330K |
|
|
NVO
3161
CALL
Novo Nordisk
NVO
$203B
| $610K | ﹤0.01% |
35,600
-10,200
| -22% | -$178K |
|
|
PGNX
3162
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $610K | ﹤0.01% |
64,660
+25,305
| +64% | +$253K |
|
3163
InterContinental Hotels
IHG
$23.5B
| $609K | ﹤0.01% |
11,315
-58
| -0.5% | -$3K |
|
3164
CALL
IMAX
IMAX
$2.73B
| $609K | ﹤0.01% |
17,900
+1,100
| +7% | +$35.9K |
|
|
XIFR
3165
XPLR Infrastructure LP
XIFR
$1.08B
| $609K | ﹤0.01% |
18,414
+17,675
| +2,392% | +$537K |
|
|
JONE
3166
DELISTED
Jones Energy, Inc.
JONE
| $609K | ﹤0.01% |
11,934
+8,683
| +267% | +$617K |
|
3167
News Corp Class B
NWS
$18.3B
| $608K | ﹤0.01% |
45,014
-28,822
| -39% | -$371K |
|
3168
Phibro Animal Health
PAHC
$1.44B
| $607K | ﹤0.01% |
21,614
+12,454
| +136% | +$351K |
|
3169
Theravance Biopharma
TBPH
$877M
| $607K | ﹤0.01% |
16,475
+12,857
| +355% | +$411K |
|
|
3170
CALL
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.9B
| $607K | ﹤0.01% |
13,800
-144,600
| -91% | -$6.19M |
|
3171
Chegg
CHGG
$98.4M
| $606K | ﹤0.01% |
71,807
+1,401
| +2% | +$10.8K |
|
3172
iShares S&P India Nifty 50 Index Fund
INDY
$567M
| $606K | ﹤0.01% |
18,750
+4,868
| +35% | +$146K |
|
|
WBMD
3173
PUT
DELISTED
WebMD Health Corp.
WBMD
| $606K | ﹤0.01% |
+11,500
| New | +$587K |
|
3174
CALL
AGNC Investment
AGNC
$12.6B
| $605K | ﹤0.01% |
30,400
+12,700
| +72% | +$245K |
|
3175
ATI
ATI
$30.5B
| $604K | ﹤0.01% |
33,579
+29,605
| +745% | +$556K |
|
Similar funds
Barclays's Q1 2017 Portfolio in Review
As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $6.86B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.
- Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
- Barclays's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $427M.
- Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
- Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
- Barclays opened 572 new positions and closed 393 in Q1 2017.
- Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.
Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.